Health Care

NERA's Global Health Care Practice covers the full range of litigation, regulatory/reform, public policy, and business strategy questions that arise in this complex industry. Our health economists have analyzed hundreds of mergers involving hospitals, health insurers, physicians, pharmaceuticals, and medical device companies. Many of these mergers have been reviewed by both US and European antitrust authorities. Our litigation experience covers antitrust issues such as monopolization, price fixing, unfair methods of competition, exclusive dealing, and other vertical restraints issues, such as those posed by integrated health care systems.

In the area of public policy, our economists in the US and Europe have worked with governments as well as purchasers and providers of health care around the world to create competitive markets, develop alternative administrative strategies, and enact realistic health care reforms that can improve both the efficiency and the fairness of health systems around the world. Our policy work has been used by organizations such as the European Commission, World Trade Organization, and US Trade Representatives to improve the environment for pharmaceutical research and development.

Name Title Location Phone Email
Dr. Lawrence Wu President San Francisco +1 415 291 1007
Dr. Graeme Hunter Managing Director New York City +1 212 345 7724
Prof. Dr. Frank P. Maier-Rigaud Managing Director
Head of Competition Economics Europe
+49 30 700 1506 80
+32 2 674 8818
+33 1 70 75 0180
Dr. Thomas McCarthy Managing Director
Health Care Practice Chair
Los Angeles +1 213 346 3005
James Mellsop Managing Director Auckland
+64 9 928 3290
+64 4 819 2550
+61 2 8864 6536
Dr. Ramsey Shehadeh Managing Director New York City +1 212 345 6089
Dr. Subramaniam (Subbu) Ramanarayanan Director New York City
Los Angeles
+1 212 345 0745
+1 213 346 3038
Grant Saggers Director London +44 20 7659 8802
Dr. Paul Wong Associate Director Los Angeles +1 213 346 3026
Dr. Alexandre Carbonnel Senior Consultant/Principal Paris
+33 1 70 75 01 60
+32 2 674 8815
Dr. Garrett Glasgow Senior Consultant San Francisco +1 415 291 1029
Dr. Yun Ling Consultant Los Angeles +1 213 346 3032
Dr. Emily Walden Consultant Washington, DC +1 202 466 9220
Dr. Michael Baye Affiliated Academic Washington, DC +1 202 466 9298
Dr. Alyssa Lutz Affiliated Consultant Los Angeles +1 714 545 3000
Title Type Author
Taking Stock of the Efficiencies Defense: Lessons from Recent Health Care Merger Revi... Published Article Dr. Subramaniam Ramanarayanan
Expert Witnesses in Competition Disputes Published Article By Dr. David Blackburn, Nathan Blalock, Dr. Subbu Ramanarayanan, and Dr. Paul Wong
Testimony Before the United States House Committee on the Judiciary, Subcommittee on ... Testimony Dr. Lawrence Wu
Paper Trail: Review of a Recent Working Paper on the Effect of Copay Coupons on Drug ... Published Article Bryan Ray and Dr. Subbu Ramanarayanan
Diversion Analysis as Applied to Hospital Mergers: A Primer Published Article By Dr. Subramaniam (Subbu) Ramanarayanan
A Profile of Professor Martin S. Gaynor (Director, FTC Bureau of Economics) Published Article By Dr. Subramaniam (Subbu) Ramanarayanan
High Court Brings Economics Back To Pay-For-Delay Analysis Published Article By Dr. Sumanth Addanki, Dr. Alan Daskin, and Dr. Christine Siegwarth Meyer
An Inside Look at Monopsony Issues in the FTC's Express Scripts-Medco Merger Investig... Published Article By John Scalf with Rani Habash of Dechert LLP
How Much Does that Medication Cost? A Study of Medicare Beneficiaries' Knowledge of O... Study By Dr. Eugene Ericksen and Melissa Pittaoulis
An Analysis of Price Effects from Drug Shortages for Independent Pharmacies and the P... Working Paper By Dr. Graeme Hunter